在老年人中,新诊断出多发性骨髓瘤的功能状态与治疗接收和治疗结果的关联
Christopher Edward Jensen1, Tzy-Mey Kuo2, Matthew R LeBlanc3
1Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC.
JCO clinical cancer informatics
|February 6, 2024
概括
残疾严重影响多发性骨髓瘤 (MM) 的老年人接受家庭卫生 (HH) 服务的死亡率. 严重的功能残疾预示着早期死亡,而中度残疾增加了急性护理需求.
科学领域:
- 血液瘤学 血液瘤学
- 老年医学 老年医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多发性骨髓瘤 (MM) 是老年人常见的一种癌症,通常与残疾和大量医疗保健使用有关.
- 这一群人经常使用家庭卫生 (HH) 服务,但残疾,HH使用和MM治疗之间的相互作用尚未得到充分理解.
研究的目的:
- 研究新诊断多发性骨髓瘤的老年人诊断前残疾,家庭卫生服务利用和治疗结果之间的关系.
- 检查功能状态如何影响该患者群体的死亡率和医疗保健利用率.
主要方法:
- 利用SEER-Medicare数据集识别了在2010-2017年间被诊断患有MM的66岁以上的成年人,他们之前曾使用过HH服务.
- 使用结果和评估信息集 (OASIS) 对日常生活活动的综合评分来评估残疾.
- 分析了死亡率,MM导向疗法接收和医疗保健利用模式.
主要成果:
- 在37,280名患有MM的老年人中,18.2%的人在诊断前使用了HH服务.
- 中等残疾人与轻度残疾人接受MM治疗的情况类似,但与严重残疾人相比,急性护理的利用率更高.
- HH使用者具有更大的并发症负担和增加的死亡率 (调整后3年死亡率的风险比:1.59). 严重的功能障碍强烈预测了诊断后的死亡率.
结论:
- 功能障碍是使用HH服务的老年MM患者早期死亡的关键预测因素.
- 中度残疾与可比的治疗强度相关,但急性护理利用率增加.
- 识别先前使用HH的患者可以帮助预测在MM治疗开始期间需要密集支持的需求.
更多相关视频
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
9.8K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
相关概念视频
Classification of Illness
7.5K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.5K
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
